health and fitness
mardi 5 avril 2022
The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S.
Manufacturers said lab testing revealed that the authorized dosage of the drug was not sufficiently potent against BA.2.
from NYT > Health https://ift.tt/qVM5PbF
via
health&fitness
Aucun commentaire:
Enregistrer un commentaire
‹
›
Accueil
Afficher la version Web
Aucun commentaire:
Enregistrer un commentaire